A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
PHASE1
This is a Phase 1/1B, non-randomized, open-label, dose-escalation study of ...
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
PHASE2
The purpose of this study was to determine the activity of two doses of rob...
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
PHASE1
This is a Phase 1B/2, non-randomized, dose-escalation, multicenter, open-la...